Shuo Qi Selected Research

Neoplasms (Cancer)

3/2024	JS-K Combined with a Melanin-Based Theranostic Agent: A Novel Sequential Delivery Strategy to Enhance the Near-Infrared Fluorescence Imaging of Pancreatic Ductal Adenocarcinoma.
12/2023	Rational design of NIR-II molecule-engineered nanoplatform for preoperative downstaging and imaging-guided surgery of orthotopic hepatic tumor.
1/2022	Targeted Multifunctional Nanoplatform for Imaging-Guided Precision Diagnosis and Photothermal/Photodynamic Therapy of Orthotopic Hepatocellular Carcinoma.
1/2021	Plasmonic-doped melanin-mimic for CXCR4-targeted NIR-II photoacoustic computed tomography-guided photothermal ablation of orthotopic hepatocellular carcinoma.
1/2020	Concordance Study in Hepatectomy Recommendations Between Watson for Oncology and Clinical Practice for Patients with Hepatocellular Carcinoma in China.
12/2018	Clinical massage therapy for patients with cancer-related fatigue protocol of a systematic review.
11/2014	Amphiphilic lipid derivatives of 3'-hydroxyurea-deoxythymidine: preparation, properties, molecular self-assembly, simulation and in vitro anticancer activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuo Qi Research Topics

Disease

7	Neoplasms (Cancer) 03/2024 - 11/2014
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2019
1	Hypersensitivity (Allergy) 04/2024
1	Adenocarcinoma 03/2024
1	Bites and Stings (Sting) 11/2023
1	Ischemic Stroke 11/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Obesity 01/2023
1	Dehydration (Water Stress) 06/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Klatskin Tumor 08/2020
1	Portal Hypertension 01/2020
1	Hemorrhage 06/2019
1	Stomach Neoplasms (Stomach Cancer) 06/2019
1	Thrombocytopenia (Thrombopenia) 06/2019
1	Abdominal Pain (Pain, Abdominal) 04/2019
1	Diarrhea 04/2019
1	Dyspepsia (Indigestion) 04/2019
1	Crohn Disease (Crohn's Disease) 04/2019
1	Fatigue 12/2018
1	Pain (Aches) 07/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2018

Drug/Important Bio-Agent (IBA)

3	Melanins (Melanin)IBA 03/2024 - 01/2021
2	PlatinumIBA 01/2022 - 01/2021
2	polydopamineIBA 01/2022 - 01/2021
1	AllergensIBA 04/2024
1	Proteins (Proteins, Gene)FDA Link 04/2024
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2023
1	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 12/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2023
1	ElementsIBA 11/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	AndrogensIBA 01/2023
1	Peptides (Polypeptides)IBA 06/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	indolepropanol phosphate (IPP)IBA 01/2022
1	Contrast MediaIBA 01/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	AntibodiesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	BismuthIBA 08/2020
1	serum P-component (CIt)IBA 06/2019
1	shenqi fuzhengIBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	InterferonsIBA 01/2019
1	NucleosidesIBA 11/2014
1	LipidsIBA 11/2014

Therapy/Procedure

3	Precision Medicine 03/2024 - 01/2021
3	Therapeutics 11/2023 - 11/2014
2	Computer-Assisted Surgery (Image Guided Surgery) 03/2024 - 12/2023
2	Photothermal Therapy 12/2023 - 01/2022
1	Immunotherapy 01/2023
1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Operative Surgical Procedures 08/2020
1	Hepatectomy 01/2020
1	Injections 06/2019
1	Drug Therapy (Chemotherapy) 06/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2019
1	Acupuncture Therapy 04/2019
1	Massage (Zone Therapy) 12/2018
1	Length of Stay 07/2018
1	Decompression 03/2018